secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001493152-23-005199
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell shareholders approve quorum amendment and elect directors at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved raising quorum to two holders representing at least 33 1/3% of outstanding shares.
- All seven director nominees elected; votes ranged from 3.63M to 3.74M for each.
- MNP LLP ratified as auditor with 6,651,809 votes for, none against, 11,560 abstain.
- New omnibus equity incentive plan approved; 19,200 RSU grant to CEO ratified.
- 15,518,018 common shares outstanding; 6,663,370 shares represented at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223005199/0001493152-23-005199-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223005199/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005199

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer